Latest Rabies virus Stories
A genetically-modified version of the rabies virus is helping scientists at Harvard to trace neural pathways in the brain, a research effort that could one day lead to treatments for Parkinson's disease and addiction.
RESEARCH TRIANGLE PARK, N.C., Sept. 28 /PRNewswire/ -- Of the many threats to human health, rabies is not often considered a serious concern in the U.S. because of its relative rarity.
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
Vesicular stomatitis virus (VSV) is a virus in the family Rhabdoviridae. Rabies is in the same family. VSV infects insects and animals and is important to farmers in certain regions of the world where it can infect cattle. It is a common laboratory virus used for studying the Rhabdoviridae family and viral evolution. It is the prototypic member of the vesiculovirus genera of the Rhabdovirus family. The genome is a single molecule of negative-sense RNA that encodes five major proteins.
The rabies virus is neurotropic virus, transmissible through the saliva of animals, that causes fatal disease in human and animals. Rabies is the type species of the Lyssavirus genus of Rhabdovirdae family. They are enveloped and single stranded RNA genome with negative-sense. All replication takes place in the cytoplasm. The virus has a bullet-like shape. Rabies enters the host cells through the endosomal transport pathway after receptor binding. After entry transcription of the viral...